Here are eight things to know:
1. Orthopedics sales dropped 0.7 percent in the first quarter, hitting $2.3 billion. U.S. sales were $1.2 billion, a nearly 1 percent decline, while international sales were only down 0.3 percent to $948 million.
2. The company’s hip sales hit $352 million in the first quarter, up 2.9 percent over the same period last year. The U.S. sales were up 3 percent to $209 million; international hip sales were $143 million.
3. Knee sales in the U.S. were up 0.8 percent to $246 million, and there was a 4.8 percent growth in international knee sales, which hit $152 million. Overall, knee sales were up 2.3 percent to $398 million.
4. Spine sales dropped 3.6 percent to $933 million in the first quarter, driven by a 5.5 percent decline in U.S. spine sales. International spine sales dropped 1 percent.
5. Trauma sales were flat at $642 million in the first quarter. The company reported 2.6 percent growth in U.S. sales, which was offset by a 3.8 percent decrease in international trauma sales.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
